Merge Healthcare Launches eFilm Mobile

Merge Healthcare Launches eFilm Mobile
New Apple iPhone(R) app brings eFilm Workstation(R) users a new world of mobile workflow 

MILWAUKEE, Mar 02, 2010 (BUSINESS WIRE) -- Merge Healthcare, a leading health IT solutions provider, today announced the release of eFilm Mobile, an exciting new extension of the eFilm Workstation franchise. This mobile device application provides users of eFilm Workstation v3.3 secure access to worklists and studies from their iPhone(R) or iPod touch(R), bringing many key components of medical imaging workflow to the palm of their hand.

"It is a unique and well-thought out application that was easy to set-up and easy to use," says Dr. Roman Klufas at Open MRI of New England. "The real value is having the ability to see my worklist and take action, from anywhere, via my iPhone. I depend upon my eFilm Workstation to get my reads done, but there are always time sensitive studies that require immediate attention no matter where I am. eFilm Mobile will allow me to control eFilm from the palm of my hand, and direct eFilm to forward the study to a radiologist who is available to read the study on their diagnostic workstation, without disrupting whatever I am doing. It's a huge timesaver."

To leverage the knowledge base of its vast eFilm user community, Merge has launched a submission form on its eFilm Community web site for users to post the creative ways in which they plan on using eFilm Mobile to improve their workflow. Users who submit their entries will be entered into a drawing for one of several new Apple iPad(R) devices. "Our new application has such a potential to effect major lifestyle change for radiologists and those involved in their workflow," says Nancy Koenig, Merge President, "that we expect our users will be able post many useful tips for the rest of the eFilm community. This is an active and sophisticated group of users, and the feedback we've received so far from our development partners has been very exciting."

The iPhone version of eFilm Mobile is available on the Apple App Store(R). The eFilm Mobile App connects with 3G and wireless networks, allowing users to:

-- Connect their iPhone to multiple eFilm Workstations

-- Allow multiple iPhone connections to eFilm Workstation

-- Interact with and view worklists remotely and in real-time

-- View images; including pan, zoom, window-level

-- Remotely control eFilm Workstation to have eFilm send studies to another DICOM device

"eFilm Mobile, as well as the underlying mobile technology we developed, expands Merge Healthcare's leadership position in the stand-alone diagnostic workstation market," said Justin Dearborn, Merge Healthcare CEO. "Responding to the needs of our customers and increasing the value of eFilm Workstation has driven this innovation. We believe it reinforces our leadership in Radiology and in Health IT."

With tens of thousands of downloads and licensed users worldwide, eFilm Workstation continues its legacy as one of the easiest-to-use DICOM viewers. A free, 30-day trial of eFilm Workstation 3.3 is available for download at www.merge.com/efilm. eFilm Mobile and eFilm Workstation 3.3 are available for use in the US, with a CE-marked version in development for worldwide distribution. eFilm Mobile is on display at this week's HIMSS show in Atlanta, Georgia, March 1 - 3, 2010 at Booth #3143.

Merge Healthcare develops software solutions that automate healthcare data and diagnostic workflow to create a more comprehensive electronic record of the patient experience. Merge products, ranging from standards-based development toolkits to fully integrated clinical applications, have been used by healthcare providers worldwide for over 20 years. Additional information can be found at www.merge.com.

iPhone(R) and iPod touch(R) are registered trademarks of Apple, Inc., Cupertino, CA.

The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words "will", "believes", "intends", "anticipates", "expects" and similar expressions, are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

SOURCE: Merge Healthcare


Media Contact:
Merge Healthcare
Julie Pekarek
Chief Marketing Officer
414.977.4254
[email protected]

Suggested Articles

Pliant Therapeutics will use the proceeds to push its lead program through midstage trials in fibrotic liver and lung diseases.

Cancer biotech Novellus has struck a deal with Plexxikon for its early- to midstage BRAF-inhibiting hopeful PLX8394.

Chinook Therapeutics is set to merge with fallen Big Pharma darling Aduro Biotech to create a kidney disease player with $180 million in cash.